Morphic to participate in march investor conferences

Waltham, mass., march 05, 2024 (globe newswire) -- morphic therapeutic (nasdaq: morf), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced its participation at investor conferences during the month of march.
MORF Ratings Summary
MORF Quant Ranking